SCOTTSDALE, ARIZONA -- (MARKET WIRE) -- October 10, 2006 -- Holmes Biopharma, Inc. (OTCBB: HLMB) announced that its research clinic in Omaha, Nebraska, was inspected last week by yet another major (Top-3) pharmaceutical company and a leading Japanese pharmaceutical company.
